S
Sarah Bettina Schwarz
Researcher at Witten/Herdecke University
Publications - 59
Citations - 423
Sarah Bettina Schwarz is an academic researcher from Witten/Herdecke University. The author has contributed to research in topics: Medicine & COPD. The author has an hindex of 10, co-authored 43 publications receiving 243 citations. Previous affiliations of Sarah Bettina Schwarz include University of Bonn.
Papers
More filters
Journal ArticleDOI
Oxytocin facilitates reciprocity in social communication.
Franny B Spengler,Dirk Scheele,Nina Marsh,Charlotte Kofferath,Aileen Flach,Sarah Bettina Schwarz,Birgit Stoffel-Wagner,Wolfgang Maier,Wolfgang Maier,René Hurlemann +9 more
TL;DR: Findings point to a central role of social synchrony in facilitating reciprocal communication between individuals via heightened OXT signaling, and Elevated OXT concentrations among synchronized individuals seem to augment the partners’ emotional expressiveness, thereby contributing to improved transmission of emotional information in social communication.
Journal ArticleDOI
Why High-Intensity NPPV is Favourable to Low-Intensity NPPV: Clinical and Physiological Reasons.
TL;DR: The aim of the current review article is to elaborate on the clinical and physiological reasons for why high-intensity NPPV is favourable to low-intensityNPPV.
Journal ArticleDOI
Long-Term Oxygen Therapy: Comparison of the German and British Guidelines.
Friederike Sophie Magnet,Sarah Bettina Schwarz,Jens Callegari,C. P. Criée,Jan Hendrik Storre,Wolfram Windisch +5 more
TL;DR: There are major differences between the 2 guidelines on long-term oxygen therapy and many of the aspects raised by the BTS guideline appear to be reasonable with regard to the current literature, clinical experience and prescription practices.
Journal ArticleDOI
Is Outpatient Control of Long-Term Non-Invasive Ventilation Feasible in Chronic Obstructive Pulmonary Disease Patients?
Sarah Bettina Schwarz,Jens Callegari,Christine Hamm,Wolfram Windisch,Friederike Sophie Magnet +4 more
TL;DR: Outpatient control of long-term NIV in a hospital setting is feasible and has the capacity to identify stable COPD patients in whom NIV therapy is sufficient according to predefined criteria.
Journal ArticleDOI
Interfaces and ventilator settings for long-term noninvasive ventilation in COPD patients
Jens Callegari,Friederike Sophie Magnet,Steven Taubner,Melanie Berger,Sarah Bettina Schwarz,Wolfram Windisch,Jan Hendrik Storre +6 more
TL;DR: This real-life trial identified the FFM as the predominantly used interface in COPD patients undergoing long-term NIV, likely to be influenced by higher IPAP levels, which form part of the basis for successful application of HI-NIV in clinical practice.